AH Bio Fund II, L.P.

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

AH Bio Fund II, L.P. sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.

Stakes it holds

AH Bio Fund II, L.P. has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).

• Nautilus Biotechnology, Inc.SCHEDULE 13D/A Jun 4, 2026 to Sep 11, 2026²
• EQRx, Inc.SC 13D/A Dec 27, 2021 to Nov 17, 2023³